drugset
drugset / Trial / NCT05346601

Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers

NCT05346601 ↗

Phase 1 Completed 16 enrolled Chipscreen Biosciences, Ltd. H & J CRO International, Inc. · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to further study the pharmacokinetic characteristics of Chiauranib Capsule in Healthy Volunteers with High Fat Diet.

Timeline

Start
2022-06-02
Primary completion
2022-06-28
Completion
2022-06-28

Drugs

EvaluationDrugModalityDoseRoute
Subject IBCASERTIB Small molecule 50 mg Oral

Indications

No indication recorded.